Cover Image
市場調查報告書

神經修復、再生手術的全球市場分析:各產品 、手術內容 、各領域的未來預測

Nerve Repair And Regeneration Market Analysis By Product (Biomaterials, Neurostimulation and Neuromodulation Devices, SCS, DBS, SNS, VNS, GES), By Surgery (Direct nerve repair/Neurorrhaphy, Nerve grafting, and Others) And Segment Forecasts to 2024

出版商 Grand View Research, Inc. 商品編碼 368013
出版日期 內容資訊 英文 81 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經修復、再生手術的全球市場分析:各產品 、手術內容 、各領域的未來預測 Nerve Repair And Regeneration Market Analysis By Product (Biomaterials, Neurostimulation and Neuromodulation Devices, SCS, DBS, SNS, VNS, GES), By Surgery (Direct nerve repair/Neurorrhaphy, Nerve grafting, and Others) And Segment Forecasts to 2024
出版日期: 2016年07月26日 內容資訊: 英文 81 Pages
簡介

Title:神經修復、再生手術的全球市場分析:各產品 (生醫材料,神經刺激、調整設備,脊髓刺激設備,深腦部刺激器,薦椎神經刺激設備,迷走神經刺激設備,胃電刺激設備)、手術內容 (神經直接修復、縫合,神經移植等)、各領域的未來預測 (到2024年)

全球神經修復、再生手術市場,到2024年預計達到157億美元的規模。市場成長的主要原因,是知名度的提高和患病人數的增加,政府的財政支援、醫療費償付制度,持續性技術開發等。

本報告提供全球神經修復、再生手術的相關市場相關分析,整體市場規模的變化、預測 (過去3年、今後9年份) ,及主要推動及阻礙市場要素,各產品、各手術內容、各地區的詳細趨勢,主要企業簡介、產業策略、市場佔有率等調查評估。

第1章 分析方法、範圍

第2章 摘要整理

第3章 神經修復、再生產業的未來展望

  • 市場明細
  • 市場規模、成長率預測
  • 神經修復、再生市場動態
    • 推動市場要素分析
      • 來自政府的資金援助的擴大
      • 技術進步,新的治療方法的引進
    • 阻礙市場要素分析
      • 法律上的課題
      • 高額的治療費
  • 重要度高的市場機會
  • 波特的五力分析
  • 競爭環境
    • 市場定位分析 (各產品、地區的存在感,策略性配合措施)
  • 神經修復、再生市場PESTEL分析

第4章 神經修復、再生市場各產品的未來展望

  • 神經修復、再生的全球市場佔有率:各產品內容 (最新值、預測值)
  • 生醫材料
    • 市場規模的估計值、預測值:以金額為準 (過去3年、今後9年份)
  • 神經刺激、調節設備
    • 市場規模的估計值、預測值:以金額為準 (過去3年、今後9年份)
    • 脊髓刺激設備的市場規模 (過去3年、今後9年份)
    • 深腦部刺激器的市場規模 (過去3年、今後9年份)
    • 薦椎神經刺激設備的市場規模 (過去3年、今後9年份)
    • 迷走神經刺激設備的市場規模 (過去3年、今後9年份)
    • 胃電刺激設備的市場規模 (過去3年、今後9年份)

第5章 神經修復、再生市場各手術內容的未來展望

  • 神經修復、再生的全球市場佔有率:各用途 (最新值、預測值)
  • 直接神經修復/神經縫合
    • 市場規模的估計值、預測值:以金額為準 (過去3年、今後9年份)
  • 神經移植
  • 幹細胞療法
  • 神經刺激、調節手術

第6章 神經修復、再生市場各地區的未來展望

  • 北美
    • 市場規模的估計值、預測值:各產品 (過去3年、今後9年份)
    • 市場規模的按估計值、預測值:手術內容 (過去3年、今後9年份)
    • 美國市場
      • 市場規模的估計值、預測值 (過去3年、今後9年份)
    • 加拿大市場
  • 歐洲
    • 英國市場
    • 德國市場
    • 法國市場
  • 亞太地區
    • 印度市場
    • 中國市場
    • 日本市場
  • 南美
    • 巴西市場
    • 墨西哥市場
  • 中東、非洲
    • 南非市場

第7章 競爭環境

  • AxoGen, Inc.
    • 企業概要
    • 財務成果
    • 產品比較分析
    • 策略性配合措施
  • Baxter International, Inc.
  • Boston Scientific, Inc.
  • St. Jude Medical, Inc.
  • Cyberonics, Inc.
  • Integra Lifesciences Corporation
  • Medtronic plc.
  • Stryker Corporation
  • Polyganics B.V.

圖表一覽

目錄

The global nerve repair and regeneration market is expected to reach USD 15.7 billion by 2024, according to a new report by Grand View Research, Inc. The demand for neurological disorder devices and therapies is expected to exhibit an upsurge over the forecast period owing to the rising awareness, the increasing incidence rate, the favorable government funding and reimbursement policies, and the continual technological advances offered by the key players of the industry. According to the American Physiological Society, approximately 12,000 spinal Cord Injuries (SCI) are recorded every year in the U.S. The majority of these injuries take place due to sporting accidents, gunshot wounds, car accidents, and falls.

In January 2016, The EU Horizon 2020 program funded a research project 'AUTOSTEM' launched by the NUI Galway's Regenerative Medicine Institute (REMEDI) amounting toUSD 6.73 million. This project is to develop a robotic stem cell production factory, involved in fully automated manufacturing of stem cells in large volumes; thus, having an edge over the old traditional techniques. Also, this technique will treat a range of therapies pertaining tocancer,arthritis, diabetes and other complications.

Further key findings from the report suggest:

The neurostimulation and neuromodulation segment dominated the product segment of the market due to the increasing awareness about the devices coupled with the surgingnumber of central nervous system disorders in the population

North America dominated the market in 2015 owing to the technological advancements in the region and the introduction of new devices by the manufacturers. In 2015, U.S proved to be the most potential market. The rise in number of cases withinjuries in the Central Nervous System (CNS), including injuries to the spinal cord and the brain,and increase in the governmentinitiatives and funding,as well as funding fromvarious other agencies were some of the major reasons responsible for the growth.

According to the report published by the Florida University, annually,more than 2 million people sufferfromtraumatic injuries of the brain in the US and a minimum of 10,000 people suffered with spinal cord injuries.The CNS injuries are a consequence of incompletely elucidated biochemical pathological phenomenon. This lack of complete understanding in the field drives the urgency for ramping up R&D efforts to develop novel neurotherapeutic approaches.

In March 2016, Baxter International, Inc. completed the CE marking, the indication for marketing of 'HEMOPATCH', the ready-to-use surgical patch in the European market. This patch was approved for use in dural defect repair, for treatingtraumatic injuries of the brain, CNS, andas a surgical sealant to contain leakage of bodily fluids in otherbody parts, oras a hemostatic device to prevent the loss of blood.

APAC is expected to be the fastest growing region of the nerve repair and regeneration market. Aging population, technological advancements, and unmet medical needs in this region are some of the reasons for the growth of the market

In February 2016, Indian scientists working for Revita Life Sciences and Bioquark, Inc. gained permission to conduct clinical trials in 20 clinically dead patients to bring specific parts of their central nervous system back to life. Combination of therapies are to be applied including injecting the brain with stem cells, cocktail of peptides, use of lasers and nerve stimulation techniquesthat have been proven successful in reviving comatose patients.A blend of regenerative medicine tools and treatment devices are to be employed to achieve success with such a complex undertaking.

Manufacturers are collaboratingwith the aim of combining the use of innovative devices and therapies to improve treatment efficiency and provide better therapy outcomes

In November 2012, UCB (Euronext Brussels) and NewBridge Pharmaceuticals entered into an agreement to engage in geographical expansion of its core products (Neupro, Vimpat, and Cimzia)to include majority of the African and Middle east countries in its distribution channels. On the other hand, Newbridge Pharmaceuticals is to focus on product commercialization, gaining regulatory approvals from local bodies, and perform pharmacovigilance. This agreement is estimated to elevate the uptake of products related to CNS and immunologic diseases in the Middle-east and Africa region.

Some key players of this market include Polyganics B.V., St. Jude Medical, Inc., Stryker Corporation, AxoGen, Inc., and others

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope &assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Nerve Repair and Regeneration- Industry snapshot and key buying criteria, 2016 - 2024

Chapter 3. Nerve Repair and RegenerationIndustry Outlook

  • 3.1. Nerve repair and regeneration market segmentation
  • 3.2. Nerve repair and regeneration market size and growth prospects, 2016 - 2024
  • 3.3. Nerve repair and regeneration: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increased government funding and recommendations
      • 3.3.1.2. Technological advances and introduction of new therapies by global players of this market.
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Legal issues
      • 3.3.2.2. Higher cost of treatment
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Nerve repair and regeneration: competitive landscape
    • 3.6.1. Competitive landscape: Market position analysis (based on products, regional presence, and strategic initiatives)
  • 3.7. Nerve repair and regeneration PESTEL analysis, 2015
    • 3.7.1 Nerve repair and regeneration technology: Future aspects

Chapter 4. Nerve Repair and Regeneration Product Outlook

  • 4.1. Nerve repair and regeneration market share by product, 2016 & 2024
  • 4.2. Biomaterials
    • 4.2.1. Biomaterials market estimates, 2013 - 2015 (USD Million)
    • 4.2.2. Biomaterials market forecasts, 2016-2024 (USD Million)
  • 4.3. Neurostimulation and Neuromodulation Devices
    • 4.3.1. Neurostimulation and neuromodulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.2. Neurostimulation and neuromodulation devices market forecasts, 2016-2024 (USD Million)
    • 4.3.3. Spinal cord stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.4. Spinal cord stimulation devices market forecasts, 2016-2024 (USD Million)
    • 4.3.5. Deep brain stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.6. Deep brain stimulation devices market forecasts, 2016-2024 (USD Million)
    • 4.3.7. Sacral nerve stimulation devices market estimates, 2013 - 2015(USD Million)
    • 4.3.8. Sacral nerve stimulation devices market forecasts, 2016-2024 (USD Million)
    • 4.3.9. Vagus nerve stimulation devices market estimates, 2013 - 2015(USD Million)
    • 4.3.10. Vagus nerve stimulation devices market forecasts, 2016-2024 (USD Million)
    • 4.3.11. Gastric electric stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.12. Gastric electric stimulation devices market forecasts, 2016-2024 (USD Million)

Chapter 5. Nerve Repair and RegenerationSurgery Outlook

  • 5.1. Nerve repair and regeneration market share by application, 2016 & 2024
  • 5.2. Direct nerve repair/neurorrhaphy
    • 5.2.1. Direct nerve repair/neurorrhaphy market estimates, 2013 - 2015(USD Million)
    • 5.2.2. Direct nerve repair/neurorrhaphy market forecasts, 2016-2024 (USD Million)
  • 5.3. Nerve grafting
    • 5.3.1. Nerve grafting market estimates, 2013 - 2015(USD Million)
    • 5.3.2. Nerve grafting market forecasts, 2016-2024 (USD Million)
  • 5.4. Stem cell therapy
    • 5.4.1. Stem cell therapy market estimates 2013 - 2015(USD Million)
    • 5.4.2. Stem cell therapy forecasts, 2016-2024 (USD Million)
  • 5.5. Neurostimulation and neuromodulation surgeries
    • 5.5.1. Neurostimulation and neuromodulation surgeries market estimates 2013 - 2015(USD Million)
    • 5.5.2. Neurostimulation and neuromodulation surgeries market forecasts, 2016-2024 (USD Million)

Chapter 6. Nerve Repair and Regeneration RegionalOutlook

  • 6.1. North America
    • 6.1.1. North America nerve repair and regeneration market estimates, byproduct, 2013 - 2015(USD Million)
    • 6.1.2. North America nerve repair and regeneration market forecasts, byproduct, 2016-2024 (USD Million)
    • 6.1.3. North America nerve repair and regeneration market estimates, bysurgery, 2013- 2015 (USD Million)
    • 6.1.4. North America nerve repair and regeneration market forecast, bysurgery, 2016-2024 (USD Million)
      • 6.1.4.1. U.S.
      • 6.1.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015(USD Million)
      • 6.1.4.1.2. Nerve repair and regeneration market forecasts, 2016-2024 (USD Million)
      • 6.1.4.2. Canada
      • 6.1.4.2.1. Nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.1.4.2.2. Nerve repair and regeneration market forecasts, 2016-2024 (USD Million)
  • 6.2. Europe
    • 6.2.1. Europenerve repair and regeneration market estimates, byproduct 2013 - 2015(USD Million)
    • 6.2.2. Europe nerve repair and regenerationmarket forecast, byproduct, 2016-2024 (USD Million)
    • 6.2.3. Europe nerve repair and regeneration market estimates bysurgery, 2013 - 2015 (USD Million)
    • 6.2.4. Europe nerve repair and regenerationmarket forecast bysurgery, 2016-2024 (USD Million)
      • 6.2.4.1. UK
      • 6.2.4.1.1. Nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.2.4.1.2. Nerve repair and regenerationmarketforecasts, 2016-2024 (USD Million)
      • 6.2.4.2. Germany,
      • 6.2.4.2.1. Nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.2.4.2.2. Nerve repair and regenerationmarket forecasts, 2016-2024 (USD Million)
      • 6.2.4.3. France
      • 6.2.4.3.1. Nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.2.4.3.2. Nerve repair and regenerationmarket forecasts, 2016-2024 (USD Million)
  • 6.3. Asia Pacific
    • 6.3.1. Asia Pacific nerve repair and regeneration market estimates, byproduct, 2013 -2015 (USD Million)
    • 6.3.2. Asia Pacific nerve repair and regenerationmarket forecasts, byproduct, 2016 - 2024 (USD Million)
    • 6.3.3. Asia Pacific nerve repair and regeneration market estimates, byapplication, 2013 -2016 (USD Million)
    • 6.3.4. Asia Pacificnerve repair and regenerationmarket forecasts, byapplication, 2016 - 2024 (USD Million)
      • 6.3.4.1. India
      • 6.3.4.1.1. Nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.3.4.1.2. Nerve repair and regenerationmarketforecasts, 2016-2024 (USD Million)
      • 6.3.4.2. China
      • 6.3.4.2.1. Nerverepair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.3.4.2.2. Nerve repair and regeneration marketforecasts, 2016-2024 (USD Million)
      • 6.3.4.3. Japan
      • 6.3.4.3.1. Nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.3.4.3.2. Nerve repair and regenerationmarket forecasts, 2016-2024 (USD Million)
  • 6.4. Latin America
    • 6.4.1. Latin America nerve repair and regeneration market estimates, byproduct, 2013 -2015 (USD Million)
    • 6.4.2. Latin America nerve repair and regeneration forecasts, byproduct, 2016 - 2024 (USD Million)
    • 6.4.3. Latin America nerve repair and regeneration market estimates, by surgery, 2013 -2016 (USD Million)
    • 6.4.4. Latin America nerve repair and regeneration forecasts, by surgery, 2016 - 2024 (USD Million)
      • 6.4.4.1. Brazil
      • 6.4.4.1.1. Nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.4.4.1.2. Nerve repair and regenerationmarket forecasts, 2016-2024 (USD Million)
      • 6.4.4.2. Mexico
      • 6.4.4.2.1. Nerve repair and regenerationmarketestimates, 2013 - 2015(USD Million)
      • 6.4.4.2.2. Nerve repair and regenerationmarket forecasts, 2016-2024 (USD Million)
  • 6.5. MEA
    • 6.5.1. MEA nerve repair and regeneration market estimates, byproduct, 2013 -2015 (USD Million)
    • 6.5.2. MEA nerve repair and regeneration forecasts, byproduct, 2016 - 2024 (USD Million)
    • 6.5.3. MEA nerve repair and regeneration market estimates, by surgery, 2013 -2016 (USD Million)
    • 6.5.4. MEA nerve repair and regeneration forecasts, by surgery, 2016 - 2024 (USD Million)
      • 6.5.4.1. South Africa
      • 6.5.4.1.1. South Africa nerve repair and regeneration marketestimates, 2013 - 2015(USD Million)
      • 6.5.4.1.2. South Africa nerve repair and regenerationmarket forecasts, 2016-2024 (USD Million)

Chapter 7. CompetitiveLandscape

  • 7.1. AxoGen, Inc.
    • 7.1.1. CompanyOverview
    • 7.1.2. FinancialPerformance
    • 7.1.3. ProductBenchmarking
    • 7.1.4. StrategicInitiatives
  • 7.2. Baxter International, Inc.
    • 7.2.1. CompanyOverview
    • 7.2.2. FinancialPerformance
    • 7.2.3. ProductBenchmarking
    • 7.2.4. StrategicInitiatives
  • 7.3. Boston Scientific, Inc.
    • 7.3.1. CompanyOverview
    • 7.3.2. FinancialPerformance
    • 7.3.3. ProductBenchmarking
    • 7.3.4. StrategicInitiatives
  • 7.4. St. Jude Medical, Inc.
    • 7.4.1. CompanyOverview
    • 7.4.2. FinancialPerformance
    • 7.4.3. ProductBenchmarking
    • 7.4.4. StrategicInitiatives
  • 7.5. Cyberonics, Inc.
    • 7.5.1. CompanyOverview
    • 7.5.2. FinancialPerformance
    • 7.5.3. ProductBenchmarking
    • 7.5.4. StrategicInitiatives
  • 7.6. Integra Lifesciences Corporation
    • 7.6.1. CompanyOverview
    • 7.6.2. FinancialPerformance
    • 7.6.3. ProductBenchmarking
    • 7.6.4. StrategicInitiatives
  • 7.7. Medtronic plc.
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. ProductBenchmarking
    • 7.7.4. StrategicInitiatives
  • 7.8. Stryker Corporation
    • 7.8.1. Company Overview
    • 7.8.2. FinancialPerformance
    • 7.8.3. ProductBenchmarking
    • 7.8.4. StrategicInitiatives
  • 7.9. Polyganics B.V.
    • 7.9.1. CompanyOverview
    • 7.9.2. FinancialPerformance
    • 7.9.3. ProductBenchmarking
    • 7.9.4. StrategicInitiatives

List of Tables

  • TABLE 1: Nerve repair and regeneration market - Industry snapshot &key buying criteria, 2013 - 2024
  • TABLE 2: Global nerve repair and regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 3: Global nerve repair and regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 4: Global nerve repair and regeneration market, by region, 2013 - 2024 (USD Million)
  • TABLE 6: Nerve repair and regeneration - Key market driver analysis
  • TABLE 7: Nerve repair and regeneration - Key market restraint analysis
  • TABLE 8: North America nerve repair and regenerationmarket, byproduct 2013 - 2024 (USD Million)
  • TABLE 9: U.S. nerve repair and regenerationmarket, byproduct, 2013 - 2024 (USD Million)
  • TABLE 1: U.S.nerve repair and regeneration, by surgery, 2013 - 2024 (USD Million)
  • TABLE 11: Canada nerve repair and regenerationmarket, byproduct, 2013 - 2024 (USD Million)
  • TABLE 12: Canada Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
  • TABLE 13: Europe Nerve Repair and Regenerationmarket,byproduct, 2013 - 2024 (USD Million)
  • TABLE 14: Europe Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
  • TABLE 15: UK Nerve Repair and Regenerationmarket, byproduct, 2013 - 2024 (USD Million)
  • TABLE 16: UK Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
  • TABLE 17: Germany Nerve Repair and Regeneration market, byproduct, 2013 - 2024 (USD Million)
  • TABLE 18: Germany Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million
  • TABLE 19: AsiaPacific Nerve Repair and Regenerationmarket, byproduct, 2013 - 2024 (USD Million)
  • TABLE 20: AsiaPacific Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
  • TABLE 21: Japan Nerve Repair and Regeneration market,byproduct, 2013 - 2024 (USD Million)
  • TABLE 22: Japan Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 23: China Nerve Repair and Regeneration market, byproduct, 2013 - 2024 (USD Million)
  • TABLE 24: China Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 25: Latin America Nerve Repair and Regeneration market,byproduct, 2013 - 2024 (USD Million)
  • TABLE 26: Latin America Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 27: Brazil Nerve Repair and Regenerationmarket,byproduct, 2013 - 2024 (USD Million)
  • TABLE 28: Brazil Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
  • TABLE 29: Mexico Nerve Repair and Regenerationmarket,byproduct, 2013 - 2024 (USD Million)
  • TABLE 30: Mexico Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
  • TABLE 31: MEA Nerve Repair and Regenerationmarket,byproduct, 2013 - 2024 (USD Million)
  • TABLE 32: MEA Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
  • TABLE 33: South Africa Nerve Repair and Regenerationmarket,byproduct, 2013 - 2024 (USD Million)
  • TABLE 34: South Africa Nerve Repair and Regenerationmarket, by surgery, 2013 - 2024 (USD Million)
Back to Top